原発性胆汁性肝硬変治療薬の世界市場

【英語タイトル】Global Primary Biliary Cirrhosis Drug Sales Market Report 2017

QYResearchが出版した調査資料(QYR802A4434)・商品コード:QYR802A4434
・発行会社(調査会社):QYResearch
・発行日:2018年1月4日
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポート(2018年版)では、原発性胆汁性肝硬変治療薬の世界市場について調査・分析し、原発性胆汁性肝硬変治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、原発性胆汁性肝硬変治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・原発性胆汁性肝硬変治療薬市場概要
・原発性胆汁性肝硬変治療薬のメーカー別販売量・メーカー別シェア
・原発性胆汁性肝硬変治療薬の世界市場:種類別販売量・市場シェア
・原発性胆汁性肝硬変治療薬の世界市場:用途別販売量・市場シェア
・原発性胆汁性肝硬変治療薬の世界市場:地域別販売量・市場シェア
・原発性胆汁性肝硬変治療薬のアメリカ市場規模
・原発性胆汁性肝硬変治療薬の中国市場規模
・原発性胆汁性肝硬変治療薬のヨーロッパ市場規模
・原発性胆汁性肝硬変治療薬の日本市場規模
・原発性胆汁性肝硬変治療薬の東南アジア市場規模
・原発性胆汁性肝硬変治療薬のインド市場規模
・原発性胆汁性肝硬変治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・原発性胆汁性肝硬変治療薬のコスト分析・価格動向
・原発性胆汁性肝硬変治療薬の産業チェーン(サプライチェーン分析)
・原発性胆汁性肝硬変治療薬のマーケティング戦略・販売チャネル、流通業者
・原発性胆汁性肝硬変治療薬市場への影響要因分析
・原発性胆汁性肝硬変治療薬の世界市場予測
・原発性胆汁性肝硬変治療薬のアメリカ市場予測
・原発性胆汁性肝硬変治療薬の中国市場予測
・原発性胆汁性肝硬変治療薬のヨーロッパ市場予測
・原発性胆汁性肝硬変治療薬の日本市場予測
・原発性胆汁性肝硬変治療薬の東南アジア市場予測
・原発性胆汁性肝硬変治療薬のインド市場予測
・原発性胆汁性肝硬変治療薬の種類別世界市場予測
・原発性胆汁性肝硬変治療薬の用途別世界市場予測
...
【レポートの概要】

In this report, the global Primary Biliary Cirrhosis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Primary Biliary Cirrhosis Drug for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Primary Biliary Cirrhosis Drug market competition by top manufacturers/players, with Primary Biliary Cirrhosis Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Primary Biliary Cirrhosis Drug Sales Market Report 2017
1 Primary Biliary Cirrhosis Drug Market Overview
1.1 Product Overview and Scope of Primary Biliary Cirrhosis Drug
1.2 Classification of Primary Biliary Cirrhosis Drug by Product Category
1.2.1 Global Primary Biliary Cirrhosis Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Primary Biliary Cirrhosis Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Budesonide
1.2.4 FFP-104
1.2.5 GSK-2330672
1.2.6 MBX-8025
1.2.7 NGM-282
1.2.8 Others
1.3 Global Primary Biliary Cirrhosis Drug Market by Application/End Users
1.3.1 Global Primary Biliary Cirrhosis Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Primary Biliary Cirrhosis Drug Market by Region
1.4.1 Global Primary Biliary Cirrhosis Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.4.3 China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.4.4 Europe Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.4.5 Japan Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.4.7 India Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Primary Biliary Cirrhosis Drug (2012-2022)
1.5.1 Global Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2022)

2 Global Primary Biliary Cirrhosis Drug Competition by Players/Suppliers, Type and Application
2.1 Global Primary Biliary Cirrhosis Drug Market Competition by Players/Suppliers
2.1.1 Global Primary Biliary Cirrhosis Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Primary Biliary Cirrhosis Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Primary Biliary Cirrhosis Drug (Volume and Value) by Type
2.2.1 Global Primary Biliary Cirrhosis Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Primary Biliary Cirrhosis Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Primary Biliary Cirrhosis Drug (Volume and Value) by Region
2.3.1 Global Primary Biliary Cirrhosis Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Primary Biliary Cirrhosis Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Primary Biliary Cirrhosis Drug (Volume) by Application

3 United States Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
3.1 United States Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
3.1.1 United States Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
3.2 United States Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
3.3 United States Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
3.4 United States Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

4 China Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
4.1 China Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
4.1.1 China Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
4.1.2 China Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
4.2 China Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
4.3 China Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
4.4 China Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

5 Europe Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
5.1 Europe Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
5.1.1 Europe Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
5.2 Europe Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
5.3 Europe Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
5.4 Europe Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

6 Japan Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
6.1 Japan Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
6.1.1 Japan Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
6.2 Japan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
6.3 Japan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
6.4 Japan Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

7 Southeast Asia Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

8 India Primary Biliary Cirrhosis Drug (Volume, Value and Sales Price)
8.1 India Primary Biliary Cirrhosis Drug Sales and Value (2012-2017)
8.1.1 India Primary Biliary Cirrhosis Drug Sales and Growth Rate (2012-2017)
8.1.2 India Primary Biliary Cirrhosis Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Primary Biliary Cirrhosis Drug Sales Price Trend (2012-2017)
8.2 India Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Players
8.3 India Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Type
8.4 India Primary Biliary Cirrhosis Drug Sales Volume and Market Share by Application

9 Global Primary Biliary Cirrhosis Drug Players/Suppliers Profiles and Sales Data
9.1 AlbireoPharma
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 CymaBay Therapeutics, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Dr. Falk Pharma GmbH
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Enanta Pharmaceuticals, Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 GlaxoSmithKline Plc
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Intercept Pharmaceuticals, Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 MediGene AG
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 NGM Biopharmaceuticals, Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Virobay Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Primary Biliary Cirrhosis Drug Maufacturing Cost Analysis
10.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
10.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Primary Biliary Cirrhosis Drug Market Forecast (2017-2022)
14.1 Global Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Primary Biliary Cirrhosis Drug Price and Trend Forecast (2017-2022)
14.2 Global Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Primary Biliary Cirrhosis Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Primary Biliary Cirrhosis Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Primary Biliary Cirrhosis Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Primary Biliary Cirrhosis Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Primary Biliary Cirrhosis Drug Price Forecast by Type (2017-2022)
14.4 Global Primary Biliary Cirrhosis Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Primary Biliary Cirrhosis Drug
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Budesonide Product Picture
Figure FFP-104 Product Picture
Figure GSK-2330672 Product Picture
Figure MBX-8025 Product Picture
Figure NGM-282 Product Picture
Figure Others Product Picture
Figure Global Primary Biliary Cirrhosis Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Primary Biliary Cirrhosis Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Primary Biliary Cirrhosis Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers
Figure 2017 Primary Biliary Cirrhosis Drug Sales Share by Players/Suppliers
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Primary Biliary Cirrhosis Drug Revenue Share by Players
Table 2017 Global Primary Biliary Cirrhosis Drug Revenue Share by Players
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Type (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Type (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Revenue Growth Rate by Type (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Region (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Region in 2016
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Region (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Revenue Growth Rate by Region in 2016
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Region (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Region in 2016
Table Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Primary Biliary Cirrhosis Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Primary Biliary Cirrhosis Drug by Application (2012-2017)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Figure Europe Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table Europe Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table Europe Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Figure Japan Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Figure India Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players (2012-2017)
Figure India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Players in 2016
Table India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type (2012-2017)
Figure India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Type in 2016
Table India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application (2012-2017)
Figure India Primary Biliary Cirrhosis Drug Sales Volume Market Share by Application in 2016
Table AlbireoPharma Basic Information List
Table AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table CymaBay Therapeutics, Inc. Basic Information List
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Dr. Falk Pharma GmbH Basic Information List
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Enanta Pharmaceuticals, Inc. Basic Information List
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Intercept Pharmaceuticals, Inc. Basic Information List
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table MediGene AG Basic Information List
Table MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table NGM Biopharmaceuticals, Inc. Basic Information List
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Virobay Inc. Basic Information List
Table Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Growth Rate (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Global Market Share (2012-2017
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Biliary Cirrhosis Drug
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Primary Biliary Cirrhosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Players in 2016
Table Major Buyers of Primary Biliary Cirrhosis Drug
Table Distributors/Traders List
Figure Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Primary Biliary Cirrhosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Primary Biliary Cirrhosis Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Primary Biliary Cirrhosis Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[原発性胆汁性肝硬変治療薬の世界市場] (コード:QYR802A4434)販売に関する免責事項を必ずご確認ください。
★調査レポート[原発性胆汁性肝硬変治療薬の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆